Grant: Knowledge Synthesis Grant
McGill University
$100,000.00
Adolescent cannabis consumption and risk of depression. An evidence-based approach
EF 2015-16
Résumé
Cannabis is the most commonly used illegal drug by young people globally. The main pharmacologically active cannabinoid principle in the Cannabis sativa plant, (−)-trans-Δ9-tetrahydrocannabinal (delta-9-THC), likely mediates most of its psychoactive and mood-related effects. This is known to be achieved by activation of the brain cannabinoid CB1 receptors.
Canadian teenagers are among the highest consumers of cannabis in the world. About one quarter of Canadian youth aged 15–24 reported using cannabis in 2013. Epidemiological studies and translational studies in Dr Gobbi's lab have confirmed that cannabis consumption at a young age is associated with a higher risk of depression and anxiety in adulthood, even after controlling for confounding factors. Many confirmatory longitudinal epidemiological studies have been published on this subject, but systematic reviews and meta-analyses evaluating the global risk of depression after adolescent cannabis consumption have not been performed, nor communicated to Canadian youth, educators, and families.
The overall aim of this knowledge synthesis proposal is to systematically review and carry out a meta-analysis about the epidemiological studies published in the last 20 years regarding the long-term effects of adolescent cannabis use on the risk of developing mood-related disorders and to communicate this knowledge to our community.
The principal applicant is Dr. Gabriella Gobbi, psychiatrist and neuroscientist at McGill University, world-renowned expert in mood disorders and the cannabinoid system. She acted as an expert witness for the Canadian Senate for Bill C-10 concerning cannabis consumption in adolescence and has been a speaker at international conferences on this topic.
The knowledge user is Dr Mark Ware, Executive Director of the Canadian Consortium for Investigations of Cannabinoids (CCIC). The CCIC is a federally-registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents. The CCIC will publish the final meta-analysis on its website, and it will distribute the audiovisual material at conferences, meetings and official events. Professors Nancy Mayo, epidemiologist, and Nandini Dendukuri, biostatistician, will assist in performing the meta-analysis. Dr. Jill Buruff, staff librarian and an expert in mental health, will help with publications research.
Collaborators are: Dr Nancy Posel, Director of Patient Education Office (DPE) at the MUHC, who will assist with the production of audiovisual materials. Dr Skye Barbic (UBC), who will help disseminate knowledge in Western Canadian communities.
The proposal's outputs are: 1) To increase awareness in the scientific community (health care stakeholders, scientists, doctors) about the risk of depression linked to cannabis use during adolescence with evidence-based data. 2) To increase knowledge at the level of the public, in particular young people and parents, by creating educational material in the form of written pamphlets, tutorials, and videos. 3) To influence policy-makers, decision-makers, health care administrators, and community leaders in making rational decisions concerning the health and mental consequences of cannabis consumption in vulnerable and minor subjects.
Programme
Knowledge Synthesis Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
345532
Name
Gobbi Gabriella
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Knowledge Synthesis Grant
Projecttitle
Adolescent cannabis consumption and risk of depression. An evidence-based approach
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Adolescence; Cannabis; Depression; Knowledge Synthesis; Marijuana; Meta-Analysis
Abstract
<html>
<body>
<p>Cannabis is the most commonly used illegal drug by young people globally. The main pharmacologically active cannabinoid principle in the <em>Cannabis sativa</em> plant, (−)-trans-Δ<sup>9</sup>-tetrahydrocannabinal (delta-9-THC), likely mediates most of its psychoactive and mood-related effects. This is known to be achieved by activation of the brain cannabinoid CB<sub>1</sub> receptors.</p>
<p>
<br> Canadian teenagers are among the highest consumers of cannabis in the world. About one quarter of Canadian youth aged 15–24 reported using cannabis in 2013. Epidemiological studies and translational studies in Dr Gobbi's lab have confirmed that cannabis consumption at a young age is associated with a higher risk of depression and anxiety in adulthood, even after controlling for confounding factors. Many confirmatory longitudinal epidemiological studies have been published on this subject, but systematic reviews and meta-analyses evaluating the global risk of depression after adolescent cannabis consumption have not been performed, nor communicated to Canadian youth, educators, and families.<br>
<br> The <u>overall aim</u> of this knowledge synthesis proposal is to systematically review and carry out a meta-analysis about the epidemiological studies published in the last 20 years regarding the long-term effects of adolescent cannabis use on the risk of developing mood-related disorders and to communicate this knowledge to our community.<br>
<br> The <u>principal applicant</u> is Dr. Gabriella Gobbi, psychiatrist and neuroscientist at McGill University, world-renowned expert in mood disorders and the cannabinoid system. She acted as an expert witness for the Canadian Senate for Bill C-10 concerning cannabis consumption in adolescence and has been a speaker at international conferences on this topic.<br>
<br> The <u>knowledge user</u> is Dr Mark Ware, Executive Director of the Canadian Consortium for Investigations of Cannabinoids (CCIC). The CCIC is a federally-registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents. The CCIC will publish the final meta-analysis on its website, and it will distribute the audiovisual material at conferences, meetings and official events.<br> Professors Nancy Mayo, epidemiologist, and Nandini Dendukuri, biostatistician, will assist in performing the meta-analysis. Dr. Jill Buruff, staff librarian and an expert in mental health, will help with publications research.<br>
<br> Collaborators are:<br> Dr Nancy Posel, Director of Patient Education Office (DPE) at the MUHC, who will assist with the production of audiovisual materials.<br> Dr Skye Barbic (UBC), who will help disseminate knowledge in Western Canadian communities.<br>
<br> The <u>proposal's outputs</u> are:<br> 1) To increase awareness in the scientific community (health care stakeholders, scientists, doctors) about the risk of depression linked to cannabis use during adolescence with evidence-based data.<br> 2) To increase knowledge at the level of the public, in particular young people and parents, by creating educational material in the form of written pamphlets, tutorials, and videos.<br> 3) To influence policy-makers, decision-makers, health care administrators, and community leaders in making rational decisions concerning the health and mental consequences of cannabis consumption in vulnerable and minor subjects.</p>
</body>
</html>
Competitiondate
201601
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gobbi, Gabriella; Ware, Mark A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~